Microbial resistance to conventional therapeutics has become a significant threat to human
society. Biofilms serve as the major virulence factor for the microorganisms by resisting the …

Surface colonization and the formation of biofilms by microbes are well acknowledged.
Communities of microorganisms are coated in these biofilms, which frequently include …

The great clinical significance of biofilm-associated infections and their inherent
recalcitrance to antibiotic treatment urgently demand the development of novel antibiofilm …

The increasing prevalence of persistent biofilm infections, such as wound infections, chronic
lung infections or medical device-related infections, which usually tolerate conventional …

Antimicrobial peptides (AMPs) are an abundant and varied group of molecules recognized
as the most ancient components of the innate immune system. They are found in a wide …

Antimicrobial peptides (AMPs) are low-molecular-weight proteins having a presence in
almost all organisms, from prokaryotes to eukaryotes, and have been a fundamental part of …

Lately, antimicrobial resistance (AMR) is increasing at an exponential rate making it
important to search alternatives to antibiotics in order to combat multi-drug resistant (MDR) …

Antimicrobial peptides (AMPs) have a broad spectrum of activity and unspecific mechanisms
of action. Therefore, they are seen as valid alternatives to overcome clinically relevant …

Growing antibiotic resistance has been reported as a great health problem throughout the
world. The threat of multidrug resistance is significantly exacerbated in biofilm-associated …

Due to rapidly increasing resistance development against conventional antibiotics, finding
novel approaches for the treatment of infections has emerged as a key health issue …